ArticleCancers2026

Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer.

Ana S Cvetanović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.